“Despite preclinical studies suggesting that isradipine may antagonize the abuse liability of cocaine , pretreatment with sustained-release isradipine did not reduce euphoric mood in cocaine-using volunteers.”
“This double-blind, within-subject, crossover laboratory … determined whether maximal dose-loading with isradipine could antagonize effects of cocaine in 12 cocaine-dependent research volunteers administered intravenous cocaine doses (0, 0.325, and 0.65 mg/kg) on different days after 5 days of treatment with isradipine or placebo.”